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Abstract
Recent investigation of Cullin 4 (CUL4) has ushered this class of multiprotein ubiquitin E3 ligases
to center stage as critical regulators of diverse processes including cell cycle regulation,
developmental patterning, DNA replication, DNA damage and repair, and epigenetic control of
gene expression. CUL4 associates with DNA Damage Binding protein 1 (DDB1) to assemble an
ubiquitin E3 ligase that targets protein substrates for ubiquitin-dependent proteolysis. CUL4 ligase
activity is also regulated by the covalent attachment of the ubiquitin-like protein NEDD8 to CUL4,
or neddylation, and the COP9 signalosome complex (CSN) that removes this important
modification. Recently, multiple WD40-repeat proteins (WDR) were found to interact with DDB1
and serve as the substrate-recognition subunits of the CUL4-DDB1 ubiquitin ligase. As more than
150–300 WDR proteins exist in the human genome, these findings impact a wide array of biological
processes through CUL4 ligase-mediated proteolysis. Here, we review the recent progress in
understanding the mechanism of CUL4 ubiquitin E3 ligase and discuss the architecture of CUL4-
assembled E3 ubiquitin ligase complexes by comparison to CUL1-based E3s (SCF). Then, we will
review several examples to highlight the critical roles of CUL4 ubiquitin ligase in genome stability,
cell cycle regulation, and histone lysine methylation. Together, these studies provide insights into
the mechanism of this novel ubiquitin ligase in the regulation of important biological processes.
Background
Ubiquitin-mediated proteolysis has been established as a
key regulatory mechanism governing almost every biolog-
ical process in the eukaryotic cell. Ubiquitination involves
the covalent attachment of a polyubiquitin chain to a
lysine residue in a substrate protein, and proceeds via
three distinct enzymatic activities. Following ATP-depend-
ent ubiquitin activation by ubiquitin activating enzyme
(E1) and ubiquitin transfer to an ubiquitin conjugating
enzyme (E2), ubiquitin is attached to substrate with the
aid of an ubiquitin ligase, or E3. Since E3s interact with
substrate directly, the dynamic regulation of E3 activity
and substrate specificity is an area of extensive explora-
tion.
CUL4 is a member of the cullin family of proteins, which
share substantial homology to CUL1 originally identified
in Caernorhabditis elegans [1]. Cullins are evolutionarily
conserved from yeast to mammals; sequence homology
spans the entire protein but is highest at the carboxy (C)
terminus, characterized by the ~200 amino acid (AA) cul-
lin homology domain [2]. Humans encode multiple cull-
ins (CUL1, CUL2, CUL3, CUL4A, CUL4B, CUL5, and
CUL7) and cullin-like proteins (PARC and APC2) [2].
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Schizosaccharomyces pombe (Pcu4), Xenopus laevis,
Caenorhabditis elegans, Drosophila melanogaster, and Arabi-
dopsis thaliana. Ancestral duplication yielded the mamma-
lian-specific CUL4A and CUL4B, which are over 80%
homologous [1]. While CUL4A and CUL4B expression
profiles are similar in human tissues [3], CUL4B possesses
an unique amino (N) terminal extension of largely
unknown function. As shown for CUL1 and CUL3 [2], tar-
geted disruption of the mouse CUL4A gene results in
embryonic lethality [4]. The decreased recovery of viable
heterozygotes also indicates CUL4A is haploinsufficient,
distinguishing it from the rest of the cullin family [4].
Two studies initially established CUL4 ubiquitin E3 ligase
activity as a modulator of key biological processes. Zhong
et al. [5] found that inactivation of CUL4 in C. elegans led
to massive rereplication of the genome and the accumula-
tion of giant nuclei containing up to 100C DNA content
in certain cells. Immunostaining suggested that replica-
tion licensing protein CDT1 was inappropriately stabi-
lized in S phase, and loss of one genomic copy of CDT1
suppressed nuclear polyploidy. This suggested that CUL4
might regulate replication licensing through CDT1 degra-
dation. CDT1 is a subunit of the pre-replication complex
and is recruited to replication origins by the origin recog-
nition complex (ORC) and Cdc6 [6]. CDT1 in turn
recruits the minichromosome maintenance hexamer
MCM2-7 that acts as replicative helicase to license origins.
Once MCM is loaded on chromatin, the origin is licensed
for DNA synthesis in S phase. CDT1 is also degraded in S-
phase to prevent relicensing of fired origins.
Independently, Higa et al. [7] reported that CDT1 is rap-
idly proteolyzed in response to ultraviolet (UV) and
gamma-irradiation (IR). This followed their earlier find-
ing that loss of geminin, an inhibitor of CDT1, led to the
CDT1-dependent rereplication and giant polyploid nuclei
[8]. Inactivation of CUL4, the RING finger protein ROC1,
or CSN subunits, suppressed CDT1 degradation in
response to DNA damage in both Drosophila and human
cells. Furthermore, CUL4 physically interacts with CDT1
and the isolated CUL4 E3 ligase can polyubiquitinate
CDT1 in vitro. These genetic and biochemical studies
established that CUL4-ROC1 ubiquitin E3 directly targets
CDT1 for degradation in S phase or after UV or IR.
Comparison of SCF prototype and CUL4
Although CUL4 was implicated in CDT1 degradation and
other biological processes (see below), the composition
and structure of CUL4 E3 ligase was only recently charac-
terized. However, the homology between cullin E3 ligases
suggest that the overall strategy of CUL4 E3 ligase for sub-
strate selection may resemble that of SCF, or CUL1-assem-
bled E3s, which usually serve as an architectural prototype
for the rest of cullin family. SCF is named for three of its
subunits: SKP1, CUL1/Cdc53, and an F-box protein [2].
The fourth subunit, the small RING finger protein ROC1/
RBX1/HRT1, cooperates with all cullins to recruit and acti-
vate E2.
CUL1 organizes the substrate receptor and E2 recruitment
modules at its amino (N) and carboxy (C) termini, respec-
tively. Structurally, CUL1 forms a stalk-like structure at its
N terminus, linked to a C terminal globular domain [9].
The N terminus consists of three cullin repeats, each
repeat consisting of a five-helix bundle [9]. CUL1 recog-
nizes substrates through the assembly of a substrate recep-
tor complex, composed of SKP1 and an F-box protein [2].
The N terminal BTB/POZ domain of the invariant adaptor
SKP1 interacts with the first cullin repeat of CUL1 (and
CUL7) [9,10]. Direct substrate recognition by SCF is per-
formed by the variable component of the substrate recep-
tor, an F-box protein. The F-box is a ~40 AA domain that
binds SKP1, and is usually located in the F-box protein
adjacent to a protein-protein interaction domain (ie:
WD40 repeats or leucine-rich repeats) for substrate bind-
ing [11,12]. Thus, F-box proteins are tethered to the SCF
core by SKP1 and recruit a spectrum of substrates through
additional domains. E2 recruitment by all cullins relies on
its tight interaction with the small RING finger protein
ROC1 [2]. ROC1 is an essential and highly conserved
RING-H2 protein, and harbors the ~70 AA RING finger
domain. Through its RING finger, ROC1 is able to recruit
and activate E2.
DDB1 was found to interact with CUL4A [13] and was
subsequently shown to be the adaptor for CUL4 E3 ligase
[14]. As an adaptor protein of CUL4 ligase [14-18], loss of
DDB1 compromises the proteolysis of a spectrum of
CUL4 substrates in vivo, including CDT1 in response to
UV [19-21], and CUL4 ubiquitination activity in vitro
[14,19]. DDB1 is evolutionarily conserved from yeast to
mammals, and is essential in mammals and Drosophila
[20,22] but not yeast [23]. In fission yeast, Rik1 is a puta-
tive DDB1 ortholog on the basis of 21% sequence identity
and copurification with Pcu4 [24].
Unlike every other cullin adaptor protein, DDB1 does not
contain the BTB/POZ fold but is formed by a cluster of
three beta propellers (BPA, BPB, BPC), spanning 100 ang-
stroms [25]. BPA and BPC resemble the two halves of an
open clamshell, which form a binding pocket. While
mutational analysis of CUL1 demonstrated that the rigid
orientation between its N and C termini is essential for
activity [9], BPB in DDB1 is joined to the BPA-BPC bind-
ing pocket by a flexible hinge. Indeed, three different con-
formations of the BPA-BPC clamshell in relation to the
cullin-binding BPB have been observed [15,25], and it
will be important to identify what factor(s) can inducePage 2 of 9
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Secondly, the CUL4A-DDB1 interface involves two dis-
tinct sites, compared to the single CUL1-SKP1 interface
[15]. The first interface involves the top surface of DDB1
BPB, notable for seven residues that are identical in all
DDB1 orthologs, and the second and fifth helices of the
first cullin repeat of CUL4A [15,25]. Despite the signifi-
cant structural difference between SKP1 and DDB1, this
interface is identical to that between SKP1 and CUL1 [15].
The second CUL4A-DDB1 interface occurs between a
unique N terminal domain of CUL4A and a peripheral
region of the DDB1 BPB [15].
WD40 repeats define the class of CUL4-DDB1 substrate 
targeting subunits
Two WD40-repeat proteins, DDB2 and the Cockayne syn-
drome protein, CSA, have been shown to associate with
DDB1, CUL4A, and CSN in mammalian cells [26]. Higa
et al. [17,27] and Jin et al. [18] recently found that human
WDR protein CDT2 (also known as L2DTL [27] and DTL
[28]) associated with CUL4B and DDB1 complexes in
vivo and regulated CDT1 proteolysis in response to DNA
damage and replication. The S. pombe CDT2 was inde-
pendently identified as CSN2-associated protein that
binds to Pcu4 [29]. These observations, together with the
observation that human CUL4 [17] and DDB1 [15,16,18]
associated with multiple WDR proteins, and the demon-
stration that each WDR protein performs an unique
CUL4-DDB1-dependent function [17,18] led to the estab-
lishment of WD40-repeat proteins as substrate-targeting
subunits of CUL4-DDB1 ubiquitin E3 ligases. The WD40
repeat spans 40–60 AA, and is notable for a tryptophan-
aspartic acid (WD) dipeptide at the C terminus [30]. The
average WD40 repeat protein has seven WDRs, with the
range being four to sixteen. The basic structural unit of
each WD40 repeat is four antiparallel beta strands, which
form beta propellers from the last beta strand of the first
WD repeat and the first three beta strands of the second
repeat. The striking conservation of the WD repeat
throughout evolution suggests that the expansive surface
area provided by the beta propeller structure is useful to
interact, organize, and stabilize multiprotein complexes.
The majority of WD40 proteins shown to bind DDB1 bear
a tandem repeat containing DXXXR/KXWDXR/K (D:
Aspartic acid; R/K: Arginine or Lysine; W: Tryptophan;
part of this region is also known as the WDXR, DXR, or
DWD boxes) [15-18]. The significance of arginine 273 in
the WDXR submotif in DDB2 is underscored by its muta-
tion to histidine (R273H) in a xeroderma pigmentosum
(XP) group E patient and its failure to bind to DDB1 [13].
Modeling of different WD40 repeat proteins revealed that
this arginine (or lysine) is exposed on the bottom face of
the barrel-shaped beta propeller structure, and mutation
of this residue in either the first or second WDXR submotif
severely reduced DDB1 binding in vitro [15-18]. How-
ever, a subset of WDR proteins able to bind DDB1 in vivo
lack this motif, suggesting that additional motifs can also
define DDB1 interaction [15-18]. With hundreds (>150–
300) of WDR proteins encoded in the human genome,
CUL4-DDB1-ROC1 might regulate a spectacular scope of
cellular processes [16,17]. To date, 49 WDR proteins have
been shown to interact with CUL-DDB1 in vivo, most by
transient overexpression in mammalian cell lines [15-18].
We have proposed to name this class of CUL4 substrate
targeting subunits as CUL4 and DDB1-associated WD40-
repeat proteins, or CDWs [17] (Figure 1). We would like
to propose to name the DXXXR/KXWDXR/K and the
related WDR-DDB1 interacting motifs as CDW box. In the
following section, we will highlight several cellular proc-
esses subject to control by CUL4-DDB1-CDW ubiquitin
E3 ligases and discuss the functions of this unique class of
ubiquitin E3 ligases.
Genomic integrity: DNA damage, DNA repair, and DNA 
replication
Genomic integrity is maintained by mechanisms that inte-
grate the detection and repair of lesions with faithful
duplication of the genome. Failure to detect or correct
DNA damage, as well as loss of checkpoint mechanisms
that prevent entry into S phase, can result in the propaga-
tion of mutations. Conversely, loss of the mechanisms
that restrict DNA replication to occur once and only once
per cell cycle can alter chromosome ploidy and produce
genomic instability.
The replication licensing factor CDT1 illustrates how DNA
damage signaling intersects with cell cycle control of DNA
replication. CDT1 is a subunit of the pre-replication com-
plex [6]. CDT1 and its associated replication licensing
activity are primarily regulated by two redundant mecha-
nisms: the specific inhibitor geminin [8], and ubiquitin-
mediated proteolysis [31]. Geminin is only found in
eukaryotes, and its tight association with chromatin-
bound CDT1 in S phase until anaphase occludes the
MCM binding site [32]. CDT1 is degraded after DNA dam-
age regardless of cell cycle phase to prevent replication in
the presence of damaged DNA [7], and in unperturbed S,
G2 and M phases to prevent rereplication [33].
Following UV or IR, CDT1 is rapidly proteolyzed via an
ATM/ATR- and CHK1/CHK2-independent pathway [7].
CDT1 proteolysis is evolutionarily conserved between
yeast, worms, frogs, flies, and mammals, and is performed
by a CUL4-DDB1-CDT2-ROC1 E3 ligase
[5,7,14,18,21,34,35]. In mammals, both CUL4A and
CUL4B target CDT1 for degradation because both iso-
forms must be inactivated by small interfering RNA
(siRNA) to detect CDT1 stabilization [7,14]. CDT1 prote-
olysis in G1 cells correlates with a delay in S phase entry,Page 3 of 9
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for DNA replication in G1 [7].
Mammals possess two redundant proteolytic pathways
for CDT1: CUL4-DDB1-CDT2 and SCFSKP2. Upon S phase
entry, CDT1 is phosphorylated on threonine 29 by cyclin
E- and cyclin A/CDK2 and directed to SCFSKP2 for proteol-
ysis [36,37]. Alternatively, a PCNA interaction motif (see
below) directs CDT1 to a CUL4-DDB1-CDT2 E3 ligase in
S/G2 phases and after DNA damage [34,38-40]. However,
CUL4-DDB1-mediated CDT1 regulation appears to be
conserved among lower metazoans [41].
Although CDT1 is proteolyzed after DNA damage or in S
phase, soluble CDT1 can be detected in association with
CUL4-DDB1 E3 complex but this pool of CDT1 is not
ubiquitinated [34]. CDT1 destruction by CUL4-DDB1-
CDT2 is activated by its selective recruitment to chromatin
by proliferating cell nuclear antigen (PCNA) [34]. Dele-
tion mutant analysis of X. laevis and human CDT1 led to
the identification of a PCNA-interaction-protein motif
(PIP box) at the extreme N terminus [18,34,42]. PCNA
can also be detected in CDT2 (L2DTL) immunoprecipi-
tates [27]. Following origin activation and the recruitment
of the enzymatic machinery for DNA synthesis, PCNA is
loaded on chromatin and acts as a processivity factor for
DNA polymerase. The chromatin association of CDT1
and CUL4-DDB1-CDT2 parallels the kinetics of PCNA
loading in S phase in Xenopus extract [18,34]. Consistent
with the architecture of the substrate receptor, DDB1 asso-
ciation with chromatin is severely compromised when
CDT2 or CDT1 are immunodepleted, or the CDT1 PIP
box is disrupted [18,34]. CDT1 bearing a mutated PIP box
or loss of CDT2 also induces rereplication in S or G2
phase [34]. Thus, PCNA orchestrates successful origin fir-
ing with inhibition of subsequent relicensing by mediat-
ing the ubiquitination of CDT1 [34], although how CUL4
E3 is specifically activated on chromatin remains a key
The CUL4-DDB1-CDW ubiquitin E3 ligaseFigure 1
The CUL4-DDB1-CDW ubiquitin E3 ligase. The structure and some biological functions of CUL4-DDB1-CDW ubiquitin E3 
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ble CUL4-DDB1-CUL2 complexes are held in check by
CSN, particularly in light of CUL4's targeting to chroma-
tin being correlated with dissociation of CSN after UV irra-
diation (see below) [26].
Work in S. pombe has indicated that CUL4-DDB1-CDT2 is
also responsible for CDT1 degradation and is a critical
integrator of a DNA damage response pathway distinct
from NER and mismatch repair [29,43,44]. This DNA
damage response consists of 2 branches, one for moderate
genotoxic stress and the other for greater levels of DNA
damage [43]. The key effector of the moderate stress
branch is Spd1, an inhibitor of ribonucleotide reductase
(RNR) assembly. Spd1 prevents RNR activation by seques-
tering the small subunit of RNR in the nucleus, away the
large subunit in the cytoplasm [44]. However, S phase
entry and DNA damage drive RNR assembly and activity
in the cytoplasm by targeting Spd1 for proteolysis in a
Pcu4-DDB1-CDT2 and CSN-dependent pathway [29,44].
Through its regulation of RNR, Spd1 was identified
upstream of translesion synthesis in the moderate stress
pathway [43]. In contrast, the extreme stress branch is
mediated by CUL4 and DDB1 independent of CSN but is
equally important for genomic stability because the muta-
tor phenotype of ddb1 null yeast can only be partially
suppressed by Spd1 deletion [43].
Nucleotide excision repair (NER)
The assembly of CUL4-DDB1-ROC1 with two different
WD40 repeat proteins, DDB2 and CSA, determines NER
pathway activation after UV irradiation [26]. Upon expo-
sure to UV, CUL4A exploits both the substrate targeting
and substrate properties of DDB2 to trigger global
genome repair [26,45]. In the absence of UV, UV-DDB
exists in a CUL4A-ROC1 complex that is inhibited by CSN
[26,45]. Immediately after UV, the UV-DDB E3 (CUL4A-
DDB1-DDB2-ROC1) is activated by dissociation from
CSN and neddylation [26], and recruited to chromatin by
DDB2. On chromatin, DDB2 recruits the repair factor
XPC, and both DDB2 and XPC are ubiquitinated [45].
Ubiquitinated DDB2 is subsequently degraded, but ubiq-
uitinated XPC is specifically retained on chromatin and
deubiquitinated over time [45]. XPC polyubiquitination
is required for NER, as addition of methylated ubiquitin
which cannot form ubiquitin-ubiquitin conjugates, inhib-
its NER in cellular extract [45]. In vivo, mutation of R273
in one of the WDXR sequences in DDB2 has been
reported in an XP patient, and fails to bind DDB1 [18].
The later activation of transcription-coupled repair after
UV depends on the assembly of CSA with CUL4-DDB1-
ROC1. CSA (Cockayne Syndrome A) and CSB (Cockayne
Syndrome B), define the two complementation groups of
Cockayne syndrome [46]. CSA bears seven WD40 repeats;
a mutation mapping to one of the WDXR-containing
WD40 repeats has been reported and abolishes DDB1
binding in vitro [18]. In vitro, a CUL4-DDB1-CSA-ROC1
complex exhibits ubiquitination activity against recom-
binant CSB [47]. In vivo, CSA-null cells fail to degrade
CSB and the restoration of transcription after transcrip-
tion-coupled repair does not occur. Interestingly, both
CSA and CDT2 interact with the DDB1 BPC but through
distinct residues, suggesting that DDB1 recruits distinct
CDWs through distinct domains [18].
Cell cycle progression
Progression through the cell cycle depends on the timely
and ordered elimination of both positive and negative
regulators of cyclin-dependent kinases (CDKs). CDK acti-
vation requires its association with a cyclin subunit, and
cyclin protein levels are the net result of synthesis and
ubiquitin-mediated proteolysis. CDK activation and
assembly is also negatively regulated by cyclin-dependent
kinase inhibitors (CDKIs) [48].
SCF is best characterized for its control of the G1/S transi-
tion, and SCF-mediated destruction of both G1 cyclins
and CDKIs is evolutionarily conserved [49]. Two key tar-
gets of SCF, cyclin E and the CDKI p27Kip1, are also subject
to control by CUL4-DDB1 [21]. Inactivation of CUL4 in
Drosophila, and CUL4A alone in mammals, produces G1
arrest which can be counteracted by concomitant loss of
Dacapo (the single Drosophila CDKI) or p27 by RNA
interference (RNAi). Cyclin E also accumulates after Dro-
sophila CUL4 or human CUL4A and CUL4B RNAi. Phos-
phorylation-dependent, p27 degradation by SCFSkp2 can
be recapitulated in mammalian cell extracts supple-
mented with cyclin E/CDK2 [50]. Cell extracts depleted of
CUL4A or DDB1 by siRNA still possess p27 degradation
activity, suggesting that SCFSKP2 and CUL4A-DDB1 act
independently [21]. In contrast, SKP2 has also been
reported to interact with CUL4-DDB1 by coupled trans-
fection and coimmunoprecipitation assays [51]. While
this observation suggests that the leucine-rich repeat pro-
tein SKP2 instead serves as the substrate targeting subunit
for p27, this study also demonstrated that CUL1 and
CUL4 act independently because CUL1 ablation by siRNA
in mammalian cells did not affect p27 protein stability
after adenoviral infection with DDB1 [51]. Furthermore,
since several F-box proteins with WD40 repeats (mouse
FBXW1/beta-TRCP, FBXW5, and FBXW8), can bind DDB1
in vitro [16], the significance of such CUL4-F-box-protein
assemblies should be investigated.
Besides the identification of the CDW(s) that recognize
p27 and cyclin E, several open questions about CUL4
structure and regulation remain. First, what determines
whether a substrate is recognized by CUL4A, CUL4B, orPage 5 of 9
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its differential regulation by CAND1, CSN, and neddyla-
tion? CAND1 was identified as an inhibitor of SCF assem-
bly [52,53], and its interaction with the cullin family is
regulated by the cullin neddylation/deneddylation cycle
[52-54]. Ablation of Drosophila CAND1 by RNAi greatly
affects armadillo (the Drosophila homolog of beta-cat-
enin) protein levels but not cyclin E, while CSN5 RNAi
has the opposite effect [21]. Since cyclin E is a target of
both SCFFbw7/Ago and CUL4-DDB1, this suggests that
CUL4 deneddylation is particularly critical for proper
function in vivo. Third, what degron sequences besides
the PIP box, or post-trasnslational modifications, specify
CUL4 substrate recruitment? In this regard, a high molec-
ular weight isoform of Drosophila cyclin E accumulates
after CUL4 RNAi. Furthermore, Dacapo, but not mamma-
lian p27, contains a PIP box [55]. The Xenopus CDK
inhibitor Xic1 is recruited to PCNA by its PIP box, and its
ubiquitination on chromatin after replication initiation is
independent of CDK2-cyclin E mediated phosphorylation
[56]. Finally, how are SCF and CUL4 E3 activity coordi-
nately regulated for their common substrates? Vertebrate
p27 and Xic1 (but not Dacapo), cyclin E and CDT1 are all
regulated by SCF and CUL4 [7,21,31,57].
CUL4A-DDB1-CDT2-ROC1 also interacts with and tar-
gets the tumor suppressor protein p53, which mediates
cell cycle arrest or apoptosis in the face of genotoxic stress
[58]. In an unstressed cell, p53 protein levels are kept low
through proteolysis, and the best characterized pathway
for p53 stability includes MDM2. MDM2 (HDM2 in
human) is a variant RING finger protein, and has been
shown in vitro to catalyze monoubiquitination, but not
polyubiquitination, of p53. In vivo, MDM2 is required for
p53 proteolysis, leading to the suggestion that p53 ubiq-
uitination by MDM2 requires other cellular factors [59].
CUL4A complex may serve such a role for p53 degrada-
tion. While loss of any component of the CUL4A-ROC1-
DDB1-CDT2 complex by specific siRNAs led to the stabi-
lization of p53 protein [19], overexpression of CUL4A is
sufficient to downregulate p53 [60]. Consistent with these
data, in vivo deletion of DDB1 in mice causes p53 accu-
mulation [20]. MDM2's incorporation into the CUL4-
DDB1-CDT2-ROC1 E3 complex is essential for p53 turn-
over by CUL4: isolated CUL4 complexes displayed robust
ubiquitination activity against p53 in vitro which is
severely diminished in MDM2-/- MEFs, and can be
restored by expression of wild type MDM2 [19]. Deple-
tion of DDB1 or CDT2 abolishes CUL4 ubiquitination
activity for p53. Furthermore, inactivation of PCNA by
siRNA dramatically increases p53 protein levels in the
absence of DNA damage, and PCNA interacts tightly with
MDM2, as well as p53. MDM2 contains a recognizable
PIP box at its extreme C terminus, but the ability of a
MDM2 PIP-box deletion mutant to still bind PCNA indi-
cates that additional domains likely exist [19]. Indeed, the
selective association of MDM2 and PCNA after UV (but
not IR) triggers MDM2 proteolysis, and is accompanied
by dissociation of p53 from CUL4A, which raises the
question of how recognition of the constitutive PIP box
degron is accomplished. CDT1, MDM2 and p53 all con-
tain the PIP box, but CDT1 and MDM2 are degraded after
UV, while p53 is stabilized [19]. The presence of MDM2
as a second RING finger protein in the CUL4A-ROC1 E3
complex is also intriguing, and the functional relationship
between MDM2 and ROC1 in E2 recruitment and polyu-
biquitin chain formation is being further investigated.
Interestingly, COP1, a WDR and RING finger protein, was
also found to regulate p53 protein stability by interacting
with p53 independent of MDM2 [61]. Recently, it was
found that COP1 interacts with CUL4-DDB1 in vivo [17],
suggesting that CUL4-DDB1 may also participate in
COP1-mediated processes.
Histone modification
Chromatin dynamics is determined by two distinct mech-
anisms: post-translational modification of histone pro-
teins, and ATP-dependent nucleosome remodeling. Both
processes act on the nucleosome, the fundamental unit of
chromatin that consists of ~146 bp of DNA wrapped
around a histone octamer (a tetramer of histone H2A and
H2B and a tetramer of histone H3 and H4). The globular
domain of histones interacts with DNA, while a flexible
tail domain protrudes from the nucleosome and is subject
to multiple modifications, including phosphorylation,
acetylation, ubiquitination, and methylation [62]. The
number and type of histone modifications are translated
into the alteration of chromatin structure which underlie
the temporal and spatial control of gene expression, hete-
rochromatin formation, DNA replication, and DNA repair
[63]. Recent studies indicate that CUL4-based E3 ligases
regulate histone lysine methylation associated with both
gene activation and gene silencing [17,64].
The WDR proteins WDR5 and RBBP5 are essential com-
ponents of the MLL (mixed-lineage-leukemia) histone
methyltransferase complex specific for histone H3 meth-
ylation on lysine 4 (H3K4) [65]. H3K4 can be mono-
(me1), di- (me2), or tri-methylated (me3), and tri-methyl-
ated H3K4 marks almost all active transcription promot-
ers and is part of epigenetic control. Loss of WDR5
severely abrogates H3K4me1 and me3, with less effect on
H3K4me2. WDR5 inactivation by siRNA in mammalian
cells reduced HOX gene expression, and injection of X.
laevis embryos with WDR5 morpholino resulted in severe
developmental abnormalities. Consistent with its identifi-
cation as a specific H3K4me2- and H3K4me3-binding pro-
tein, WDR5 is postulated to stimulate the conversion of
H3K4me2 to H3K4me3.Page 6 of 9
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WDR5 and RBBP5 and regulates histone H3 methylation
at K4 [17]. Like WDR5 and RBBP5, inactivation of CUL4
or DDB1 by siRNAs leads to drastic loss of H3K4me3 and
H3K4me1 [17]. In vivo, DDB1 and CUL4A can be detected
in H3K4 mono-, di-, and tri-methylated H3K4 mononu-
cleosomes. CUL4-DDB1 also associates with H3K4me3
but not unmodified H3 peptide in vitro. The interactions
between WDR5 or RBBP5 and CUL4-DDB1 and the func-
tional involvement of CUL4-DDB1 ubiquitin ligase in
H3K4 methylation support the notion that ubiquitin-
dependent proteolysis underlies the dynamic regulation
of epigenetic marks at H3K4. The ubiquitin ligase activity
of CUL4-DDB1 assembled with WDR5 and RBBP5 may
thus target a negative regulator of H3K methylation. On
the other hand, the demonstration in this study that dis-
tinct WDR proteins, WDR5 and CDT2 (L2DTL), perform
distinct biological functions through CUL4-DDB1 ligase
supports the notion that CDW identity differentiates the
biological processes influenced by CUL4-DDB1-ROC1
ubiquitination. Thus maintenance of CDT1 destruction
after DNA damage in WDR5-deficient cells and mainte-
nance of H3K4 methylation in CDT2-silenced cells estab-
lished that WDR proteins are substrate-targeting subunits
of CUL4-DDB1 ubiquitin ligases.
Polycomb group (PcG) proteins maintain the silenced
state of homeotic genes [62]. Higa et al. (2006) discovered
that CUL4-DDB1 binds the polycomb group protein EED
(embryonic ectoderm development, mammalian homo-
logue of Drosophila ESC, Extra sex comb), a WD40-repeat
subunit of the EZH2 (Enhancer of Zeste homologue 2)
methyltransferase complex [17]. The EED-EZH2-SUZ12
methyltransferase directs histone H3 methylation at
lysine 9 and lysine 27 (H3K9 and H3K27) for X chromo-
some inactivation, genomic imprinting, heterochromatin
formation, and gene silencing [62]. The specific associa-
tion of CUL4-DDB1 with tri-methylated H3K9 and
H3K27 mononucleosomes was also observed [17]. Inacti-
vation of CUL4 or DDB1 significantly abolished tri-meth-
ylation at K9 and K27, suggesting this ligase complex is
functionally involved. Thus destruction of H3K9/K27-
specific regulators by CUL4-DDB1 ubiquitin E3 ligase
might regulate these epigenetic processes [17].
In fission yeast, Pcu4-Rik1 regulates H3K9 methylation
through its recruitment of the Clr4 methyltransferase to
chromatin and this is independent of DDB1 [64]. A
requirement for CUL4 catalytic activity was shown in S.
pombe, where a Pcu4 non-neddylated mutant could not
restore gene silencing to Pcu4 null yeast [64]. Potential
targets of CUL4 ubiquitination include antagonists of his-
tone methylation [66] or histones themselves. In yeast,
mammals, and likely Drosophila, monoubiquitination of
histone H2A/H2B is a prerequisite for histone H3/H4
methylation [67]. Given the tight coupling of H2A and
H2B ubiquitination to transcriptional activation, deter-
mining if CUL4 might regulate transcription is worthy of
further study. Finally, how is CUL4 activity programmed
to accomplish monoubiquitination or polyubiquitina-
tion? DDB2 has been implicated in H2A ubiquitination
[68], and CUL4-DDB1-ROC1 devoid of CSN has been
shown to ubiquitinate H3 and H4 in vitro to promote
repair [69]. It will be interesting to analyze the contribu-
tion of E2 specificity to the processivity of CUL4 ubiquiti-
nation, since the association of the Polycomb PRC1 E3
ligase with different UbcH5 E2 isoforms has been shown
to influence H2A ubiquitination [70].
Conclusion
While our knowledge of CUL4 E3 ligases has expanded
significantly, many provocative questions remain. One
critical question is whether all WDR proteins or a subset
of them bind to CUL4-DDB1 and perform a function in
protein ubiquitination. CUL4 function in vivo should
also be addressed with genetic analysis in knockout ani-
mals or cells.
Since CUL4A amplification has been noted in breast and
hepatocellular cancer [71,72], it will be interesting to
determine if CUL4A/4B gene dosage alters tumor progres-
sion in vivo. The flexible nature of the DDB1 adaptor pro-
tein, as well as chromatin-templated ubiquitination,
suggest that CUL4's ability to recognize, stably bind, and
polyubiquitinate substrates is exquisitely regulated.
Beyond identifying new targets for CUL4-DDB1-CDW,
investigation of these regulatory mechanisms promises to
keep CUL4 E3s in the spotlight for the foreseeable future.
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